2026-01-02 - Analysis Report
Okay, here's a comprehensive report on Northrop Grumman (NOC) based on the data you provided, with simple numbers and analysis.

**1) Return Rate Comparison with S&P 500 (VOO)**

*   **Company Overview:** Northrop Grumman Corp. is a global aerospace and defense technology company.
*   **NOC Cumulative Return:** 37.27%
*   **VOO Cumulative Return:** 105.07%
*   **Divergence:** -67.8% (Current), Relative Divergence: 5.1
    *   **Analysis:** NOC has significantly underperformed the S&P 500 over the given period. The current divergence of -67.8% indicates a substantial difference in cumulative returns. The relative divergence of 5.1 suggests the current difference is near the lower end of its historical range compared to VOO.

**Alpha, Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 32.0% | 73.9% | 3.0% | 0.7 | 35.1 |
| 2017-2019  | 50.0% | 78.4% | 9.0% | 0.7 | 49.2 |
| 2018-2020  | -11.0% | 80.3% | -43.0% | 0.8 | 43.6 |
| 2019-2021  | 40.0% | 80.3% | -36.0% | 0.7 | 55.4 |
| 2020-2022  | 46.0% | 80.8% | 27.0% | 0.6 | 78.1 |
| 2021-2023  | 63.0% | 83.3% | 35.0% | 0.3 | 67.0 |
| 2022-2024  | 27.0% | 83.3% | -3.0% | 0.3 | 67.2 |
| 2023-2025  | 27.0% | 82.0% | -41.0% | 0.1 | 81.6 |

*   **CAGR:** The Compound Annual Growth Rate fluctuates, showing strong growth in some periods (e.g., 2021-2023: 63%) and declines in others (e.g., 2018-2020: -11%).
*   **MDD:** The Maximum Drawdown is consistently high, indicating significant potential for loss from peak to trough.
*   **Alpha:** Alpha varies significantly, indicating periods of outperformance (positive Alpha) and underperformance (negative Alpha) relative to the market. The later years, particularly 2023-2025, show substantial underperformance.
*   **Beta:** Beta generally ranges between 0.3 and 0.8, suggesting NOC is less volatile than the market (Beta of 1). However, the Beta has decreased in more recent periods.
*   **Cap(B):** Market capitalization has generally increased over the periods shown.

**2) Recent Stock Price Fluctuations**

*   **Current Price:** \$570.21
*   **Previous Close:** \$574.57
*   **Change:** -\$0.76
*   **5-day SMA:** \$576.46
*   **20-day SMA:** \$566.42
*   **60-day SMA:** \$578.42

    *   **Analysis:** The current price is slightly below the previous close, indicating a small recent decline. The 5-day SMA is above the 20-day SMA, which suggests a short-term upward trend. However, the 60-day SMA is above the 5-day SMA, which indicates the stock price is trending down in the mid-term view.

**3) Indicators and Signals**

*   **MRI:** 0.9 (High Investment Recommended)
*   **RSI:** 59.09
*   **PPO:** 0.24
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (3 shares - Very Safe - MRI:0.90) Dividend_2.31 Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent Divergence Change:** -0.5 (Negative - Short-term decline)
*   **Expected Return:** 0.0%

    *   **Analysis:**
        *   The MRI suggests a high investment recommendation, indicating the model views this as a relatively safe investment environment for NOC.
        *   The RSI of 59.09 is close to the overbought threshold but does not signal that the stock is currently overbought.
        *   The PPO is near zero, which indicates that the near term moving average is almost the same with the long term moving average.
        *   The Hybrid Signal recommends buying the stock and reinvesting dividends.
        *   The negative divergence change suggests some short-term downward pressure.
        *   The expected return of 0.0% is not good for investment.

**4) Recent News & Significant Events**

*   **Positive:** Merit Financial Group LLC purchased shares (positive sentiment). Northrop Grumman declared a quarterly dividend.
*   **Negative:** Why Is Northrop Grumman (NOC) Down 5.3% Since Last Earnings Report? Diversified Trust Co Sells Shares of Northrop Grumman Corporation. Northrop Grumman: An Argument For Buying At Undervaluation (Rating Downgrade)
*   **Neutral:** General news and price target updates.

    *   **Analysis:** Recent news is mixed. While there is some positive news regarding dividend declarations and share purchases, negative news regarding price declines and rating downgrades could cause concern.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean: 2.04)
*   **Target Price:** \$662.68 (Average), \$770.00 (High), \$533.00 (Low)

    *   **Analysis:** Analysts, on average, have a "Buy" rating for NOC. The average target price suggests a potential upside from the current price. The range of target prices is quite wide, indicating some uncertainty in the stock's future performance.

**5) Recent Earnings Analysis**

| 날짜       | EPS  | 매출      |
|------------|------|----------|
| 2025-10-21 | 7.69 | 10.42 B$ |
| 2025-07-22 | 8.17 | 10.35 B$ |
| 2025-04-22 | 3.33 | 9.47 B$ |
| 2024-10-24 | 7.02 | 10.00 B$ |
| 2025-10-21 | 7.02 | 10.00 B$ |

*   **Analysis:** Revenue has generally been stable, with some fluctuation. EPS has varied more significantly. The EPS on 2025-04-22 was notably lower than other periods.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | \$10.42B   | 21.37%        |
| 2025-06-30   | \$10.35B   | 21.35%        |
| 2025-03-31   | \$9.47B    | 16.69%        |
| 2024-12-31   | \$10.69B   | 18.08%        |
| 2024-09-30   | \$10.00B   | 21.07%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE     |
|--------------|-----------|---------|
| 2025-09-30   | \$15.99B  | 6.88%   |
| 2025-06-30   | \$15.47B  | 7.59%   |
| 2025-03-31   | \$14.98B  | 3.21%   |
| 2024-12-31   | \$15.29B  | 8.27%   |
| 2024-09-30   | \$14.75B  | 6.96%   |

*   **Analysis:** Revenue has been relatively consistent. The profit margin has fluctuated, and the ROE (Return on Equity) has varied from quarter to quarter, with 2025-03-31 recording a significantly lower ROE.

**7) Comprehensive Analysis (Summary)**

*   **Underperformance:** NOC has significantly underperformed the S&P 500.
*   **Mixed Signals:**
    *   Technical indicators (SMA, RSI) provide some conflicting signals.
    *   Recent news is mixed, with some positive and some negative developments.
    *   Analysts have a "Buy" rating with potential upside.
*   **Financials:** Revenue is relatively stable, but profitability metrics (profit margin, ROE) have varied.
*   **Risk:** MDD is consistently high, indicating significant potential for loss.

**Overall Conclusion:**

NOC presents a mixed picture. While analysts are generally positive and the company pays a dividend, the stock has significantly underperformed the broader market. Recent news is mixed, and there are concerns about fluctuating profitability. The high MDD indicates potential risk. Therefore, any investment decision should consider the investor's risk tolerance and investment horizon.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.